AU713527B2 - Thrombin inhibitors - Google Patents
Thrombin inhibitors Download PDFInfo
- Publication number
- AU713527B2 AU713527B2 AU39749/97A AU3974997A AU713527B2 AU 713527 B2 AU713527 B2 AU 713527B2 AU 39749/97 A AU39749/97 A AU 39749/97A AU 3974997 A AU3974997 A AU 3974997A AU 713527 B2 AU713527 B2 AU 713527B2
- Authority
- AU
- Australia
- Prior art keywords
- compound
- equiv
- mmol
- arh
- inhibiting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2382996P | 1996-08-12 | 1996-08-12 | |
| US60/023829 | 1996-08-12 | ||
| GB9625311 | 1996-12-05 | ||
| GBGB9625311.7A GB9625311D0 (en) | 1996-12-05 | 1996-12-05 | Thrombin inhibitors |
| PCT/US1997/014019 WO1998006396A1 (en) | 1996-08-12 | 1997-08-08 | Thrombin inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU3974997A AU3974997A (en) | 1998-03-06 |
| AU713527B2 true AU713527B2 (en) | 1999-12-02 |
Family
ID=26310558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU39749/97A Ceased AU713527B2 (en) | 1996-08-12 | 1997-08-08 | Thrombin inhibitors |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0949921B1 (enExample) |
| JP (1) | JP2000516929A (enExample) |
| AT (1) | ATE227571T1 (enExample) |
| AU (1) | AU713527B2 (enExample) |
| CA (1) | CA2262686A1 (enExample) |
| DE (1) | DE69717147T2 (enExample) |
| ES (1) | ES2185042T3 (enExample) |
| WO (1) | WO1998006396A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2406684T3 (es) | 2007-08-24 | 2013-06-07 | Marinomed Biotechnologie Gmbh | Composición antiviral que comprende un polisacárido sulfatado: iota carragenano |
| BR112015023214A8 (pt) * | 2013-03-15 | 2019-12-24 | Verseon Corp | composto, composição farmacêutica, e, uso de um composto ou composição farmacêutica |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6013788A (ja) * | 1983-07-05 | 1985-01-24 | Yamanouchi Pharmaceut Co Ltd | 新規なクマリン誘導体 |
| EP0446604A3 (en) * | 1990-03-16 | 1992-02-19 | American Cyanamid Company | Pyridine and related aza heterocycle derivatives as cardiovascular agents |
| IE912759A1 (en) * | 1990-08-06 | 1992-02-12 | Smith Kline French Lab | Compounds |
| WO1992008709A1 (de) * | 1990-11-15 | 1992-05-29 | Pentapharm Ag | Meta-substituierte phenylalanin-derivate |
| US5399564A (en) * | 1991-09-03 | 1995-03-21 | Dowelanco | N-(4-pyridyl or 4-quinolinyl) arylacetamide and 4-(aralkoxy or aralkylamino) pyridine pesticides |
| FR2695387B1 (fr) * | 1992-09-09 | 1994-10-21 | Adir | Nouveaux composés benzopyraniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
| US6506876B1 (en) * | 1994-10-11 | 2003-01-14 | G.D. Searle & Co. | LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use |
-
1997
- 1997-08-08 ES ES97937175T patent/ES2185042T3/es not_active Expired - Lifetime
- 1997-08-08 EP EP97937175A patent/EP0949921B1/en not_active Expired - Lifetime
- 1997-08-08 DE DE69717147T patent/DE69717147T2/de not_active Expired - Fee Related
- 1997-08-08 JP JP10509908A patent/JP2000516929A/ja active Pending
- 1997-08-08 CA CA002262686A patent/CA2262686A1/en not_active Abandoned
- 1997-08-08 WO PCT/US1997/014019 patent/WO1998006396A1/en not_active Ceased
- 1997-08-08 AU AU39749/97A patent/AU713527B2/en not_active Ceased
- 1997-08-08 AT AT97937175T patent/ATE227571T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0949921B1 (en) | 2002-11-13 |
| JP2000516929A (ja) | 2000-12-19 |
| ES2185042T3 (es) | 2003-04-16 |
| CA2262686A1 (en) | 1998-02-19 |
| EP0949921A1 (en) | 1999-10-20 |
| ATE227571T1 (de) | 2002-11-15 |
| DE69717147D1 (en) | 2002-12-19 |
| DE69717147T2 (de) | 2003-07-24 |
| WO1998006396A1 (en) | 1998-02-19 |
| AU3974997A (en) | 1998-03-06 |
| EP0949921A4 (enExample) | 1999-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5869487A (en) | Pyrido 3,4-B!pyrazines for use as thrombin inhibitors | |
| US5792779A (en) | Pyridinone thrombin inhibitors | |
| US5668289A (en) | Pyridinone thrombin inhibitors | |
| US5629324A (en) | Thrombin inhibitors | |
| AU703744B2 (en) | Pyridinone-thrombin inhibitors | |
| EP0934064B1 (en) | Thrombin inhibitors | |
| AU720616B2 (en) | Pyridinone thrombin inhibitors | |
| EP0971891A1 (en) | Thrombin inhibitors | |
| EP1017393A1 (en) | Pyrazinone thrombin inhibitors | |
| US6117888A (en) | Thrombin inhibitors | |
| US5792761A (en) | Thrombin inhibitors | |
| US6011038A (en) | Pyrazinone thrombin inhibitors | |
| AU713527B2 (en) | Thrombin inhibitors | |
| US6017934A (en) | Thrombin inhibitors | |
| US6087373A (en) | Thrombin inhibitors | |
| AU741766B2 (en) | Thrombin inhibitors | |
| US6004976A (en) | Thrombin inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |